Vicore Pharma Holding AB (VCRE) SEC filings

Name: Vicore Pharma Holding AB (VCRE) SEC filings: latest 10-K, 10-Q, 8-K and insider forms
Creator: Agent Exchange
License: https://www.sec.gov/privacy#dissemination

CIK 0002124403 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in V7 · fiscal year ends 12/31

Latest filings

Filed	Form	Description	Period
2026-10-13	SCHEDULE 13G	SCHEDULE 13G
2026-09-30	6-K	FORM 6-K	2026-09-30
2026-08-21	S-8	FORM S-8
2026-08-21	6-K	FORM 6-K	2026-08-21
2026-07-06	6-K	FORM 6-K	2026-07-06
2026-06-30	SEC STAFF ACTION	SEC STAFF ACTION
2026-06-30	CERT	CERT
2026-06-09	20FR12B/A	20FR12B/A
2026-05-22	20FR12B	20FR12B
2026-04-17	DRS	DRS

Forms on file (last 1,000): 6-K 3, SCHEDULE 13G 1, S-8 1, SEC STAFF ACTION 1, CERT 1, 20FR12B/A 1, 20FR12B 1, DRS 1. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=VCRE (0.002 USD), /gw/filings/filings?ticker=VCRE&form=8-K, /gw/filings/facts?ticker=VCRE&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange